Gene Symbol | DLL4 |
Entrez ID | 54567 |
Uniprot ID | Q9NR61 |
Description | delta-like 4 (Drosophila) |
Chromosomal Location | chr15: 40,929,340-40,939,072 |
Ontology | GO ID | GO Term | Definition | Evidence |
---|---|---|---|---|
BP |
GO:0000122 |
negative regulation of transcription from RNA polymerase II promoter |
Any process that stops, prevents, or reduces the frequency, rate or extent of transcription from an RNA polymerase II promoter. |
ISS |
BP |
GO:0001525 |
angiogenesis |
Blood vessel formation when new vessels emerge from the proliferation of pre-existing blood vessels. |
ISS |
BP |
GO:0001569 |
patterning of blood vessels |
The process that regulates the coordinated growth and sprouting of blood vessels giving rise to the organized vascular system. |
ISS |
BP |
GO:0001974 |
blood vessel remodeling |
The reorganization or renovation of existing blood vessels. |
ISS |
BP |
GO:0003208 |
cardiac ventricle morphogenesis |
The process in which the cardiac ventricle is generated and organized. A cardiac ventricle receives blood from a cardiac atrium and pumps it out of the heart. |
ISS |
BP |
GO:0003209 |
cardiac atrium morphogenesis |
The process in which the cardiac atrium is generated and organized. A cardiac atrium receives blood from a vein and pumps it to a cardiac ventricle. |
ISS |
BP |
GO:0003222 |
ventricular trabecula myocardium morphogenesis |
The process in which the anatomical structures of the trabecular cardiac ventricle muscle are generated and organized. |
ISS |
BP |
GO:0003344 |
pericardium morphogenesis |
The process in which the anatomical structure of the pericardium is generated and organized. |
ISS |
BP |
GO:0007165 |
signal transduction |
The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell. |
TAS |
BP |
GO:0007219 |
Notch signaling pathway |
A series of molecular signals initiated by the binding of an extracellular ligand to the receptor Notch on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription. |
TAS |
BP |
GO:0007220 |
Notch receptor processing |
The series of successive proteolytic cleavages of the Notch protein, which result in an active form of the receptor. |
TAS |
BP |
GO:0007601 |
visual perception |
The series of events required for an organism to receive a visual stimulus, convert it to a molecular signal, and recognize and characterize the signal. Visual stimuli are detected in the form of photons and are processed to form an image. |
IEA |
BP |
GO:0008015 |
blood circulation |
The flow of blood through the body of an animal, enabling the transport of nutrients to the tissues and the removal of waste products. |
TAS |
BP |
GO:0008285 |
negative regulation of cell proliferation |
Any process that stops, prevents or reduces the rate or extent of cell proliferation. |
IMP |
BP |
GO:0010596 |
negative regulation of endothelial cell migration |
Any process that decreases the rate, frequency, or extent of the orderly movement of an endothelial cell into the extracellular matrix to form an endothelium. |
IMP |
BP |
GO:0010628 |
positive regulation of gene expression |
Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA (for protein-coding genes) and the translation of that mRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form. |
IDA |
BP |
GO:0010629 |
negative regulation of gene expression |
Any process that decreases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA (for protein-coding genes) and the translation of that mRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form. |
IDA |
BP |
GO:0030217 |
T cell differentiation |
The process in which a precursor cell type acquires characteristics of a more mature T-cell. A T cell is a type of lymphocyte whose definin characteristic is the expression of a T cell receptor complex. |
ISS |
BP |
GO:0035912 |
dorsal aorta morphogenesis |
The process in which the anatomical structures of the dorsal aorta are generated and organized. The dorsal aorta is a blood vessel in a single-pass circulatory system that carries oxygenated blood from the gills to the rest of the body. In a single-pass circulatory system blood passes once through the heart to supply the body once. |
ISS |
BP |
GO:0035924 |
cellular response to vascular endothelial growth factor stimulus |
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a vascular endothelial growth factor stimulus. |
IMP |
BP |
GO:0044344 |
cellular response to fibroblast growth factor stimulus |
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an fibroblast growth factor stimulus. |
IDA |
BP |
GO:0045746 |
negative regulation of Notch signaling pathway |
Any process that stops, prevents, or reduces the frequency, rate or extent of the Notch signaling pathway. |
ISS |
BP |
GO:0045747 |
positive regulation of Notch signaling pathway |
Any process that activates or increases the frequency, rate or extent of the Notch signaling pathway. |
ISS |
BP |
GO:0050767 |
regulation of neurogenesis |
Any process that modulates the frequency, rate or extent of neurogenesis, the origin and formation of neurons. |
IEA |
BP |
GO:0060579 |
ventral spinal cord interneuron fate commitment |
The process in which the developmental fate of a cell becomes restricted such that it will develop into a ventral spinal cord interneuron. Ventral spinal cord interneurons are cells located in the ventral portion of the spinal cord that transmit signals between sensory and motor neurons and are required for reflexive responses. |
IMP |
BP |
GO:0061074 |
regulation of neural retina development |
Any process that modulates the rate, frequency, or extent of neural retina development, the progression of the neural retina over time from its initial formation to the mature structure. The neural retina is the part of the retina that contains neurons and photoreceptor cells. |
ISS |
BP |
GO:0061314 |
Notch signaling involved in heart development |
The series of molecular signals initiated by binding of an extracellular ligand to a Notch receptor on the surface of the target cell and contributing to the progression of the heart over time. |
ISS |
BP |
GO:0072554 |
blood vessel lumenization |
The process in which a developing blood vessel forms an endothelial lumen through which blood will flow. |
IEA |
BP |
GO:0090051 |
negative regulation of cell migration involved in sprouting angiogenesis |
Any process that decreases the frequency, rate or extent of cell migration involved in sprouting angiogenesis. Cell migration involved in sprouting angiogenesis is the orderly movement of endothelial cells into the extracellular matrix in order to form new blood vessels contributing to the process of sprouting angiogenesis. |
IDA|IMP |
BP |
GO:1903588 |
negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis |
Any process that stops, prevents or reduces the frequency, rate or extent of blood vessel endothelial cell proliferation involved in sprouting angiogenesis. |
IDA |
BP |
GO:2000179 |
positive regulation of neural precursor cell proliferation |
Any process that activates or increases the frequency, rate or extent of neural precursor cell proliferation. |
ISS |
CC |
GO:0005886 |
plasma membrane |
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
TAS |
CC |
GO:0016021 |
integral component of membrane |
The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane. |
IEA |
MF |
GO:0005112 |
Notch binding |
Interacting selectively and non-covalently with the Notch (N) protein, a surface receptor. |
IEA |
MF |
GO:0005509 |
calcium ion binding |
Interacting selectively and non-covalently with calcium ions (Ca2+). |
IEA |
MF |
GO:0005515 |
protein binding |
Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules). |
IPI |
Domain ID | Description |
---|---|
IPR000152 |
EGF-type aspartate/asparagine hydroxylation site |
IPR000742 |
EGF-like domain |
IPR001774 |
Delta/Serrate/lag-2 (DSL) protein |
IPR001881 |
EGF-like calcium-binding domain |
IPR009030 |
Growth factor receptor cysteine-rich domain |
IPR011651 |
Notch ligand, N-terminal domain |
IPR013032 |
EGF-like, conserved site |
Pathway ID | Pathway Term | Pathway Source |
---|---|---|
hsa01522 |
Endocrine resistance |
KEGG |
hsa04330 |
Notch signaling pathway |
KEGG |
hsa04658 |
Th1 and Th2 cell differentiation |
KEGG |
hsa05224 |
Breast cancer |
KEGG |
WP3413 |
NOTCH1 regulation of human endothelial cell calcification |
WikiPathways |
WP2064 |
Neural Crest Differentiation |
WikiPathways |
WP61 |
Notch Signaling Pathway |
WikiPathways |
WP3845 |
Canonical and Non-canonical Notch signaling |
WikiPathways |
WP268 |
Notch Signaling Pathway |
WikiPathways |
WP3888 |
VEGFA-VEGFR2 Signaling Pathway |
WikiPathways |
UMLS CUI | UMLS Term |
---|---|
C0282160 |
Aplasia Cutis Congenita |
C1458155 |
Mammary Neoplasms |
Tissue | Cell Type |
---|---|
duodenum |
glandular cells |
gallbladder |
glandular cells |
kidney |
cells in tubules |
liver |
bile duct cells |
liver |
hepatocytes |
small intestine |
glandular cells |
Database Name |
---|
DisGeNET |
Gene Symbol | Entrez ID | Uniprot ID | Score |
---|---|---|---|
JAG1 |
182 |
P78504 |
0.00 |
HES1 |
3280 |
Q14469 |
0.00 |
JAG2 |
3714 |
Q9Y219 |
0.00 |
NOTCH3 |
4854 |
Q9UM47 |
0.00 |
NOTCH4 |
4855 |
Q99466 |
0.55 |
NOTCH1 |
4851 |
P46531 |
0.63 |